Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations
Description
Different modeling approaches can be used to calculate excess deaths for the COVID-19 pandemic period. We compared 6 calculations of excess deaths (4 previously published and two new ones that we performed with and without age-adjustment) for 2020-2021. With each approach, we calculated excess deaths metrics and the ratio R of excess deaths over recorded COVID-19 deaths. The main analysis focused on 33 high-income countries with weekly deaths in the Human Mortality Database (HMD at mortality.org) and reliable death registration. Secondary analyses compared calculations for other countries, whenever available. Across the 33 high-income countries, excess deaths were 2.0-2.8 million without age-adjustment, and 1.6-2.1 million with age-adjustment with large differences across countries. In our analyses after age-adjustment, 8 of 33 countries had no overall excess deaths; there was a death deficit in children; and 0.478 million (29.7%) of the excess deaths were in people <65 years old. In countries like France, Germany, Italy, and Spain excess death estimates differed 2 to 4-fold between highest and lowest figures. The R values’ range exceeded 0.3 in all 33 countries. In 16 of 33 countries, the range of R exceeded 1. In 25 of 33 countries some calculations suggest R>1 (excess deaths exceeding COVID-19 deaths) while others suggest R<1 (excess deaths smaller than COVID-19 deaths). Inferred data from 4 evaluations for 42 countries and from 3 evaluations for another 98 countries are very tenuous Estimates of excess deaths are analysis-dependent and age-adjustment is important to consider. Excess deaths may be lower than previously calculated.
Files
API_SP.DYN.CDRT.IN_DS2_en_csv_v2_3932073.csv
Files
(75.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:5f43156f3b156ab3e8f2f36ab1e01aaa
|
174.4 kB | Preview Download |
|
md5:ffa0d5eb98af72ba14fe4164592d8d35
|
190.5 kB | Download |
|
md5:8b92ec5051e82c755e20d17afc2c04e2
|
6.9 kB | Preview Download |
|
md5:c15535d6c18ce2b42a995ee899fc5bc0
|
14.5 kB | Preview Download |
|
md5:cae9cb9573aa68df4d828dc66f12ce94
|
6.5 MB | Preview Download |
|
md5:df4b4b4e29e90b36f2687577de0e74c9
|
326.3 kB | Download |
|
md5:b2add3cfe68e5f1a1e505683bda3d3a0
|
244.1 kB | Preview Download |
|
md5:cc9701590bd74bd362d18b21a88fb216
|
49.5 MB | Preview Download |
|
md5:ba224a5440deb94fa2f02a739e2a342f
|
18.8 MB | Preview Download |
Additional details
Funding
- National Institutes of Health
- Cost Effective, Synergistic Macromolecular Structure Determination, Analysis & Simulation 5R35GM122543-02